Activest Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52K Sell
329
-30
-8% -$4.06K 0.01% 274
2026
Q1
$45.9K Sell
359
-751
-68% -$93.8K 0.01% 349
2025
Q4
$135K Buy
1,110
+1,080
+3,600% +$124K 0.03% 191
2025
Q3
$3.04K Sell
30
-844
-97% -$76K ﹤0.01% 731
2025
Q2
$72.5K Buy
874
+757
+647% +$60.4K 0.02% 162
2025
Q1
$9.47K Sell
117
-114
-49% -$10.2K ﹤0.01% 408
2024
Q4
$20.8K Buy
231
+201
+670% +$19.5K 0.01% 245
2024
Q3
$2.99K Hold
30
﹤0.01% 402
2024
Q2
$2.78K Buy
+30
New +$2.69K ﹤0.01% 378
2023
Q1
Sell
-994
Closed -$80.7K 572
2022
Q4
$80.7K Sell
994
-624
-39% -$50.5K 0.02% 149
2022
Q3
$128K Buy
1,618
+924
+133% +$77.9K 0.04% 115
2022
Q2
$52K Hold
694
0.04% 94
2022
Q1
$62K Hold
694
0.04% 89
2021
Q4
$78K Sell
694
-198
-22% -$23.9K 0.05% 90
2021
Q3
$112K Sell
892
-18
-2% -$2.32K 0.07% 73
2021
Q2
$123K Sell
910
-192
-17% -$25.2K 0.09% 64
2021
Q1
$153K Buy
+1,102
New +$165K 0.13% 56

Other funds holding XBI

Activest Wealth Management's XBI Position: Q2 2026 in Review

Activest Wealth Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 8.4% in Q2 2026, selling an estimated $4.06K and leaving 329 shares worth $52K. The position accounts for 0.01% of the portfolio, ranked #274.

Activest Wealth Management first reported a position in XBI in Q1 2021 and has held it in 17 quarters since. The position peaked at $153K in Q1 2021. 327 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Activest Wealth Management held 329 shares of State Street SPDR S&P Biotech ETF worth $52K as of Q2 2026.
  • Activest Wealth Management sold 30 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $4.06K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Activest Wealth Management's portfolio in Q2 2026, its #274 holding.
  • Activest Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and has held it in 17 quarters since.
  • Activest Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $153K in Q1 2021.
  • 327 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.